Ulcerative colitis followed by the development of typical intestinal Behçet disease: A case report

Medicine (Baltimore). 2018 Feb;97(7):e9882. doi: 10.1097/MD.0000000000009882.

Abstract

Rationale: Intestinal Behçet disease (intestinal BD) and inflammatory bowel disease (IBD) share a lot of characteristics, including genetic background, clinical manifestations, and therapeutic strategies, especially the extraintestinal manifestations, such as oral ulcers, arthralgia, eye lesions, skin lesions, etc, but the coexistence of these 2 diseases are uncommon. Behçet disease with gastrointestinal involvement in ulcerative colitis (UC) patient has been reported in just 1 previous case report, but, which can not be diagnosed as definite intestinal BD based on Korean novel diagnositic criteria due to lacking the typical ileocecal ulcer.

Patient concerns: We present a 23-year-old woman with ulcerative disease who developed typical intestinal BD, which is the first case report of patient with coexisting UC and typical intestinal BD.

Diagnoses: This patient was diagnosed as coexistence of intestinal BD and UC base on the clinical manifestations, extra intestinal manifestations and typical colonoscopic findings.

Interventions: Steroid and methotrexate were administered.

Outcomes: This patient achieved clinical remission and mucosal healing.

Lessons: Coexistence of intestinal BD and UC is uncommon, and the combination with steroid, methotrexate, and 5-aminosalicylic acids is an effective therapy.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anti-Inflammatory Agents, Non-Steroidal / administration & dosage
  • Antirheumatic Agents / administration & dosage
  • Behcet Syndrome* / complications
  • Behcet Syndrome* / diagnosis
  • Behcet Syndrome* / physiopathology
  • Colitis, Ulcerative* / complications
  • Colitis, Ulcerative* / diagnosis
  • Colitis, Ulcerative* / physiopathology
  • Colonoscopy / methods*
  • Gastrointestinal Tract* / diagnostic imaging
  • Gastrointestinal Tract* / pathology
  • Glucocorticoids / administration & dosage*
  • Humans
  • Male
  • Mesalamine / administration & dosage*
  • Methotrexate / administration & dosage*
  • Remission Induction
  • Treatment Outcome

Substances

  • Anti-Inflammatory Agents, Non-Steroidal
  • Antirheumatic Agents
  • Glucocorticoids
  • Mesalamine
  • Methotrexate